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Abstract
Current evidence-based research shows that pain in hospice patients is a growing problem. A
gap in practice was identified as the current clinical practice guideline (CPG) in a hospice
center in South Carolina was outdated and not being employed. A literature review revealed
that updated CPGs provide better outcomes in pain management for end-of-life care. The
project answered the practice-focused question: In the context of hospice, what are current
evidence-based strategies for managing pain. The Stettler model and Kolcaba’s comfort
theory guided the development of the CPG. Three nurse case managers and two physicians
participated in the creation of CPG. The Grading of Recommendations, Assessment,
Development and Evaluation (GRADE) was used to critically appraise the evidence selected
for inclusion in the CPG. Only articles which scored a high or moderate on the GRADE scale
were used in the final determination. Twenty scholarly articles were originally reviewed, and
ten of those met the inclusion criteria. The updated CPG was developed using the Appraisal
of Guidelines and Evaluation (AGREE) II tool consisting of six domains. Using the AGREE
II Instrument and the scoring checklist, the CPG was reviewed by an expert panel of hospice
physicians. Of the six domains, all domains exceeded the threshold of 70%, indicating
acceptance of the domain. In addition, the final domain scored a 100%, which also indicated
acceptance of the content of the CPG. It is recommended that the hospice nurses, clinicians,
and practitioners implement this updated evidence-based pain management guideline to
prescribe pain medications. This CPG has the potential to influence social change by
providing adequate pain management for patients at end of life.
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Section 1: Nature of the Project
Introduction
According to current evidence-based research, pain in hospice patients is a
growing problem. According to the National Institute of Health (2021), more that 1.6
million Americans received hospice services in 2014, and approximately 60% of them
received these services at home. Hospice care emphasizes the deployment of an
interdisciplinary care team to support patients and their family in comfort care, pain
control, symptom management, and spiritual needs. Chi et al (2018) has found that the
patients’ pain was undertreated in end-of-life care. For my project, I have updated the
clinical practice guidelines (CPG) for pain management in a hospice center in South
Carolina. The reason for this choice was that I have seen firsthand that not all patients
receive adequate pain management that they deserve at end of life. By creating an
updated CPG, I was able to assist physicians, nurse practitioners, and nurses in providing
effective care for their patients. This guideline can serve as a means for all hospice
facilities, home care services and in-patient units to follow the same practices for end-oflife pain control.
This CPG has the potential to influence social change by providing adequate pain
management for patients at end of life. The CPG may generate a positive impact in the
health care community that oversees hospice patients in the community. Stakeholders,
which include physicians, nurse practitioners and clinical staff, will see positive
improvements in their clinical practice when this CPG is implemented. Awareness of
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basic tenets of pain management and access to practical references will now allow
physicians and nurses to care effectively for their patients at the end of life.
Problem Statement
Statistics have shown that more than 50% of patients with terminal illness
experience pain in the end-of-life stage (Hospice and Palliative Nurses Association,
2011). In this practice setting, most patients are treated with the same pain management
regimen when they are admitted for hospice service instead of being given orders based
on their diagnosis. According to Booker and Haedtke (2016), evidence-based practice
(EBP) is not widely used in hospice. Not only is this not patient-centered care, but for a
patient to sit in pain waiting for new orders is unethical. There are many patients that are
admitted to hospice every week. Some of these patients are dying from natural causes
while some of them are suffering from other chronic diseases. Some of these diseases,
such as metastatic cancers, can be debilitating.
Pain in hospice patients is a growing problem. At a hospice center located in
South Carolina, during the admission process, the same pain management regimen is
prescribed for each patient regardless of diagnosis. CPG and EBP in this setting have not
been employed for pain management. Thus, the practice problem that was the focus of
this project was inadequate pain management at the end of life for patients receiving
hospice service. The gap in nursing practice is evident at a hospice center in South
Carolina where the CPG is outdated and not consistently followed. There is also no
current CPG being used at this facility. EBP is also not being used for pain management
in this setting. Professional care providers have identified that effective pain management
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is an essential goal in providing end-of-life care (Chi et al, 2018). Despite this universally
acknowledged goal, studies of terminally ill patient’s pain experiences consistently
demonstrate that pain is not adequately managed (Herr, 2015).
This doctoral project holds significance in nursing practice because it is the duty
of clinicians to provide seamless pain management to all patients. . An evidence-based
CPG is significant to increase the quality of life and pain management for patients who
are transitioning into and currently receiving hospice care.
Purpose
There are multiple benefits that could be realized from a Doctor of Nursing
Practice (DNP) scholar updating CPG for pain management. An updated CPG has the
potential to improve the patient’s clinical course, improve patients’ quality of life, ease
caregiver stress, and improve overall satisfaction. When a person is entering the last
stages of life on hospice care, communication and shared decision-making with the dying
person and those important to them should not have to be about pain management. Pain
should be controlled from the day of admission to hospice care. The DNP prepared nurse,
along with the clinical team, can use updated CPG to allow effective pain management to
conform to their clinical diagnosis information assessed during admission, instead of
using standing orders. Adequate pain management requires the intervention of all
disciplines in a holistic approach. Unrelieved pain affects the patient's physical,
psychological, social, and spiritual well-being (Chi et al, 2018)
The gap in nursing practice was evident as the current CPG in a hospice office in
South Carolina was outdated and not consistently followed. The updated CPG has
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assisted in creating an evidence-based source to serve all providers and allow for more
standardized pain management for the patients.
This project answered the following practice focused question:
PFQ: In the context of hospice, what are current evidence-based strategies for
managing pain?’
The updated CPG has the potential to impact social change by promoting positive patient
outcomes. The overall goal was that patients will be more satisfied with pain
management resulting in an increased quality of life. An updated CPG for patients has the
potential to result in better outcomes, greater quality of life, and a smoother transition
allowing for a more peaceful death. The benefit of providing pain medication based on
the patient’s need will become apparent and more hospice and home health facilities may
adopt this protocol. These changes have the potential for improving the quality of life for
many patients and families. This updated CPG can help more than just one hospice
facility. Should this CPG prove successful, by increasing patient pain management, this
CPG can be shared with other facilities, promoting change in the hospice industry over
time.
The gap in nursing practice is evident as the current CPG in a hospice office in
South Carolina, was outdated and not consistently followed. The challenge is to assist in
adequate pain management for these patients at the end of life and ensure that they are all
receiving adequate pain control. This updated CPG is the bridge that answers the practice
question and narrows the gap in practice.
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Nature of the Doctoral Project
The literature suggested that updated CPG will provide better outcomes in pain
management for end-of-life care (Max et al., 2011). The databases that I utilized for this
CPG update included Google Scholar, the New England Journal of Medicine, CINAHL,
PubMed, and Scopus. The year range that I searched was in the last 10 years, 2010-2020,
because that provided the most up to date information. The keywords that I utilized in my
search included pain management, hospice, end of life, pain control, and clinical practice
guidelines.
To research and produce this updated CPG, I referred to the Walden University
Manual for clinical practice guideline development. This updated CPG was created for a
local hospice office in South Carolina. This facility did not have updated CPG for pain
management in place. I secured the approval of the facility administrator to use this
facility and obtained approval from Walden’s Institutional Review Board (IRB). The
facility medical director was interested in my clinical practice guideline ideas. There
were three nurse case managers, two nurse practitioners and two physicians who had
input for this CPG. This facility is currently undergoing policy and procedure changes
related to implementing new electronic medical records, and this initiative serves as an
opportunity to update the guidelines being used. The facility and implementation of the
new medical records system can be defined as resources to support the practice problem.
I developed the updated CPG using the Appraisal of Guidelines and Evaluation
(AGREE) II tool. I obtained permission from the facility to collect input from the
physicians, nurses, nurse practitioners, administrator, nurse managers, and other clinical
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leaders and gain access to the current policies, data, and admission guidelines. I reviewed
how the policies of the facility are developed and reviewed literature on the most current
clinical trials, evidence-based articles, and other literature sources that could help in
updating the hospice agency policy. This updated CPG is the bridge that answers the
practice question and fills in the gap in practice.
Significance
The stakeholders for this updated CPG are the health care workers and health care
providers. They are the nurses, physicians, nurse practitioners, physician assistants, and
all other clinical staff who work in patient care. Additional stakeholders are the patients
and family members. The effective management of pain is a time-honored goal of
healthcare. From the time of Hippocrates to the present-day Code of Medical Ethics of
the American Medical and Nursing Association, the assessment and management of a
patient's pain has been the primary responsibility of every practitioner (Brockis,2011).
According to Brockis (2011), effective pain management for a terminal patient
population is possible according to medical experts, but there are several misconceptions
about hospice and end-of-life care that persist in the medical field. Until these
misconceptions and myths are refuted and physicians, nurses, patients, and their families
are aware of the facts surrounding pain management in hospice, many patients will
continue to experience end-of-life pain. Pain relief should always be the top priority in
the treatment of hospice patients. Too much emphasis on treating other symptoms or
trying to medically manage the underlying disease in hospice care can mean that
terminally ill patients will have to wait needlessly to receive adequate pain management.
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Allowing a person to endure pain when their pain can be managed and relieved violates
the principle of beneficence because the provider is not preventing pain and therefore not
acting in the best interest of the patient. It also violates the principle of nonmaleficence
because it is causing harm and sometimes injury to the person.
This project contributes to nursing practice. Despite advances in understanding
pain physiology and available pharmacotherapies, many patients with terminal illnesses
such as cancer report untreated or undertreated pain (Carlson, 2017). Hospice programs
are geared towards providing relief from pain, both physical and emotional for the patient
and their family. The purpose behind hospice care is to make the time that hospice
patients have left as comfortable, dignified, and enjoyable as possible and to allow them
the comfort they need to die with dignity. The goal of hospice care is not to prolong life
or to medically manage patients’ chronic conditions, the goal is to provide patients with a
high-quality end of life.
Other stakeholders are the patients and their families as pain management affects
them just as it affects the clinician. Pain management should remain a high priority so
that higher quality of life can be enjoyed by the patients on hospice services. Although
death is inevitable for everyone, it should not have to be painful when there is relief
available. Many patients experience significant pain in the final months of life. In
addition to wanting to preserve as much quality of life as possible, most patients express
a preference to die outside of acute care settings, and a key element to achieving these
goals is adequate pain management and being at home with their families.
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This updated CPG has transferability to many other locations, not just the facility
for which it was created. This updated CPG can be used as a guide in other hospice
offices, home health agencies, inpatient hospice units, and in physician offices. This CPG
has the potential to influence social change by providing effective pain management to
patients at the end of life. The CPG has the potential to generate a positive impact to the
health care community that oversees hospice patients in the community. Stakeholders,
who are patients, families, and staff, have seen positive improvements in their care since
this CPG has been implemented.
Summary
In Section 1,I discussed the problem statement, project purpose, nature of the
problem, gap in practice, and significance of the project. I showed which stakeholders
have benefited from an updated CPG and how it has impacted social change. In Section
2, I discuss potential models and theories, as well as the relevance to nursing practice and
my role as the DNP student. I also introduce the project team and discuss their role in this
DNP project.
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Section 2: Background and Context
Introduction
The gap in nursing practice at this hospice office in South Carolina is the lack of a
CPG addressing pain management in patients admitted for end-of-life care. More
specifically, there is no CPG used in this facility. EBP is also not being used for pain
management in this setting. Thus, this project answered the following practice focused
question:
PFQ: In the context of hospice, what are current evidence-based strategies for
managing pain?
The updated CPG has the potential to impact social change by promoting positive patient
outcomes. The purpose of this DNP project was to develop a clinical practice guideline
update for controlling pain in hospice patients receiving end-of-life care. The goal of this
project was to provide the clinical site with a clinical practice guideline that would
support the clinical teams’ efforts to manage pain effectively based on the diagnosis of
the patient. In this section, I discuss the Stettler model, relevance of the project to nursing
practice, the local background and context, and my role as the DNP student.
Concepts, Models, and Theories
This project utilized the Stettler model (Coyne et al., 2018). The Stettler model
enables practitioners to assess how research findings and other needed evidence are
implemented into clinical practice. This model aids examination of how to utilize
evidence to create the change needed to foster patient-centered care. This model has five
phases to follow. Phase 1 consists of identifying the need for change. Phase 2 validates
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the evidence and quality of the evidence to deem whether there is a good fit in relation to
the project. In Phase 3, the evidence for change is summarized and evaluated. The project
team determined whether the evidence was acceptable to be applied practice. In Phase 4,
The project team developed the “how to” for implementation and identified the practice
implications to justify creating the change. Finally, in Phase 5, the team identified the
expected outcomes of implementing the project and will then determine whether the
goals of the EBP were achieved (see Coyne et al, 2018). The team used all four of the
following nursing concepts for this CPG update: the person, environment, health, and
nursing (Nikfarid et al, 2018).
The National Institute of Health (2021) surveyed 348 patients in 16 hospice
settings. The researchers found that 76% of these patients experienced pain, with frequent
and severe symptoms more prominent in patients with less than 15-day stays. This is a
concern given reports that suggest 70%–90% of all hospice patients both at home and in
facilities could achieve pain relief with the implementation of existing evidence and CPG
(Chi et al., 2018).
Next, I define some of the terminology used in this DNP project:
Hospice patient: A patient who is in the last 6 months of life and is admitted to
hospice care for end-of-life management (Carlson et al., 2017).
Nurse case manager: A registered nurse who cares for admitted hospice patients
in their home or at a facility (Scott-Findlay, 2006).
End of life:The last 6 months of a patient’s life. A patient is in end of life when
their prognosis is less than 6 months (Carlson et al., 2017).
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Admission standing orders: Blanket standing orders used during a patient
admission to start care (Munasinghe et al., 2011).
Palliative care: Patient and family-centered care that optimizes quality of life by
anticipating, preventing, and treating suffering (Carlson et al, 2017).
End-of-life care: The term used to describe the support and health care given
during the time surrounding death (Brockis, 2011).
The Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument
(Appendix A) is a widely used standard for assessing the methodological quality of
practice guidelines (www.agreetrust.org) This tool was used in this CPG update to assess
and evaluate the quality of the evidence. The AGREE instrument, developed by the
AGREE Enterprise, is a quantitative method for evaluating CPGs. The AGREE
instrument is a tool designed primarily to help guide developers and users in assessing the
methodological quality of guidelines.
Kolcaba’s comfort theory was used to guide the development of the CPG for the
DNP-prepared nurse (Coelho et al., 2016). The theory is considered a middle range
theory that has the potential to direct the work and thinking of all healthcare providers.
According to Kolcaba’s theory, patients can be defined as individuals, families,
institutions, or communities in need of health care. (Krinsky et al, 2014). The
environment is any aspect of the patient, family, or institutional surroundings that can be
manipulated by a nurse or loved one to enhance comfort. Health is optimal functioning in
the patient, as defined by the patient, group, family, or community (Krinsky et al., 2014).
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Relevance to Nursing Practice
The broader issue in nursing practice is that not all patients are getting the same
level of pain relief in hospice care. Patients deserve ethical treatment, and this includes
pain relief. The treatment of pain is an ethical obligation. Health science schools,
especially medical training institutions such as medical schools and nursing schools, have
the duty to teach pain management in a comprehensive fashion. The regulatory measures
taught in these schools, which limit access for patients to opioid treatments, are unethical
and should be reconsidered (Chi et al, 2018).
According to Carvalho et al. (2018), there is evidence that patients often suffer
from uncontrolled and unnecessary pain. This is inconsistent with the leges artis, and its
practical implications merit a bioethical analysis. A research article written by Herr et al.
(2010) stated that one of the goals of hospice care is a pain-free death, which is important
to everyone involved in the experience. Although pain outcomes are better in hospice
care patients than nonhospice settings, there are gaps and inconsistencies in hospice
practices of effective assessment and management of pain, which was the basis for
updating the CPG (Chi, 2018).
The CPG that most hospice facilities use was last published in 2018, and it was
published by the National Coalition for Hospice and Palliative Care National Consensus
Project for Quality Palliative Care. In that CPG, the authors stated that pain and practical
needs are systematically addressed with the patient and family throughout the continuum
of care. If present, any conditions are treated based upon current evidence and with
consideration of cultural aspects of care. However, the CPG fails to address the gap in
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pain management between patients with different diagnoses (National Coalition for
Hospice and Palliative Care National Consensus Project for Quality Palliative Care,
2018).
According to current evidence-based research, pain in hospice patients is a
growing problem. As reported by the National Institute of Health (2019), more that 1.6
million Americans received hospice services in 2014, and approximately 60% of them
received these services at home. Hospice care emphasizes the deployment of an
interdisciplinary care team to support patients and their family with comfort care, pain
control, symptom management, and spiritual needs. Chi et al (2018) has found that the
patients’ pain was undertreated in end-of-life care.
The National Hospice and Palliative Care Association (Hospice and Palliative
Nurses Association, 2011) surveyed 348 patients in 16 hospice settings. The researchers
found that 76% of these patients experienced pain, with frequent and severe symptoms
more prominent in patients with less than 15-day stays. This is a concern given reports
that suggest 70%–90% of all hospice patients both at home and in facilities could achieve
pain relief with the implementation of existing evidence and CPG (Chi et al., 2018).
In October 2015, the American Society for Pain Management created a guide for
end-of-life pain management in hospice (Herr, 2015). Herr (2015) noted that in a study of
elderly nursing home residents who were enrolled in hospice care, the prevalence of pain
was close to 60%. Based on findings of a meta-analysis of 52 studies spanning 40 years,
Brockis (2011) also found that 64% of patients with advanced cancer have pain. Onethird of all patients who were reviewed in these studies rated their pain as moderate or
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severe on a pain scale. This finding should be found as unacceptable (Hospice and
Palliative Nurses Association, 2011). Despite these findings, this clinical update did not
address the gap in pain management between patients who had different diagnoses, and at
this facility patients were still being admitted with the recommendation of pain
management standing orders on admission.
Local Background and Context
This updated CPG has the potential to impact social change by promoting positive
patient outcomes. Families will be more satisfied with the care their loved ones received.
Hospitals will be more willing to send referrals to a facility by knowing there is more
focus on end-of-life pain management. Patients will have better outcomes, greater quality
of life and a smoother transition allowing for a more peaceful death. The benefit has the
potential to provide pain medication based on diagnosis, and as the success of the CPG
becomes apparent, more hospice and home health facilities will adopt this protocol. This
can increase the quality of life for many patients and families. A current clinical guideline
can help more than just one hospice facility. Once this CPG has proven successful, this
CPG can be shared with other facilities, promoting change in the hospice industry.
This updated CPG was created using a local hospice office in South Carolina.
This office does not currently follow any CPG for its pain management protocols. I
secured the approval of the facility administrator to use this facility. The facility medical
director was very interested in my clinical practice guideline ideas. There were three
nurse case managers, two nurse practitioners, and two physicians who had input for this
CPG. This facility provided an opportunity to implement my DNP project and to create a
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CPG. This facility was undergoing policy and procedure changes related to implementing
new electronic medical records, and thus this was a perfect time to update the guidelines
being used. This facility was a perfect match to plan the CPG guidelines. The updated
CPG aligns with the facility’s mission statement: “Our goal is to offer comfort and loving
care that allows a patient to feel like family and have the best last days of their life
possible.” Updating the CPG has allowed the facility’s mission to come alive through
reducing the burden of pain and increasing the quality of life.
Federal regulations Condition of participation: Initial and comprehensive
assessment of the patient, 42 CFR Section 418.54 states that: “The medical director …
assumes overall responsibility for the medical component of the hospice’s patient care
program.” This would include adequate pain management for all patients admitted to
service. Federal article 42 CFR Section 418.50 (2015) states: “A hospice must make
drugs routinely available on a 24-hour basis, to include pain management medications.”
This updated CPG would assist in ensuring the facilities are federally compliant with
these regulations. Currently there are no state regulations that would apply to this updated
CPG.
Role of the Doctor of Nursing Practice Student
The DNP nurse has a vested interest in the clinical course of each patient. In
hospice care, this includes adequate and timely pain control for all. Being a major
contributor to the clinical team, the DNP nurse oversees the advanced planning and
implementation of guidelines and policy, for each patient under their care. The DNP
student nurse has created an updated clinical guideline, using EBP, new clinical models
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for pain management in the hospice patient. The DNP practice prepared nurse has
changed the clinical guideline to allow prescription pain medication to be based on
clinical diagnosis information on admission instead of standing orders. Good pain and
symptom management require the intervention of all disciplines in a holistic approach.
Unrelieved pain affects the patient's physical, psychological, social, and spiritual wellbeing. The DNP student has created, from the best evidence-based articles, newly
updated guideline which can assist the care team in bridging the gap in pain management
for hospice patients. With the assistance of the facility medical director, nurse
practitioners, nursing staff and support staff, the updated CPG was made possible through
collaboration, and development.
This updated CPG has the potential for transferability as, this updated CPG may
be utilized in many other hospice facilities, not just the facility where it was created. This
updated CPG can be used in other hospice offices, home health locations, inpatient
hospice units and in physician offices as a guide. Despite advances in understanding pain
physiology and available pharmacotherapies, many patients with terminal illnesses, such
as cancer, report untreated or undertreated pain, therefore this is the basis for this updated
CPG (Booker & Haedtke, 2016).
Role of the Project Team
The health care staff that are responsible for assisting this nurse in the creation of
this updated CPG were the physicians at the local hospice office, the nurse case
managers, the nurse practitioners, the facility educators, my clinical mentor, and my
preceptor for my clinical courses. The facility medical director served as the expert on
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this panel. The staff are a part of the project team by means of assisting with evidencebased clinical research, providing input on current policy and procedures for hospice
patients, and by providing the current guidelines that the office follows for pain
management. The DNP student has utilized the DNP essentials to assist in these change
actions and implementations (Zaccagnini & White, 2015).
The team was provided with the background information, including current CPG,
evidence-based methods and literature associated with the project, to review. They then
had the opportunity to share their experiences, knowledge, expertise, and relevant
information on how it may pertain to the CPG. The timeline between presenting the
materials and gathering the data from the team was 14 days. This timeline gave each
member time to process the data, review all the literature and provide feedback.
The medical director at this hospice facility has been a hospice medical director
for twenty years and has extensive knowledge in pain management, EBP implementation
and clinical guidelines. The registered nurse case managers have been caring for hospice
patients for multiple years and have seen the guidelines in use in the field and can attest
to the fact that they do not satisfy the need for pain management for the patients we serve.
The nurse practitioners in the office are hospice certified and have the highest level of
education and training in the art of hospice care. They understood the need for updated
CPG firsthand and provided information on how and when the changes should be made.
The role of these essential staff was for support, information, policy and
procedure development, evidence-based clinical needs assessment and implementation of
current CPG in the line of duty. By working with the previous CPGs, these staff members
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were aware of the changes that need to be made for the best care for a patient’s pain. All
these team members were excited to have been a part of the change that can occur from
an updated CPG.
Summary
In section two, we have discussed the concepts, models, and theories guiding the
project, relevance of the practice problem to nursing practice, local background and
context, role of the DNP student and the project team This was a critical component of
the CPG, as the input from the clinical team, who has the hands-on experience, was
extremely beneficial when reviewing EBP guidelines. In section three, we focus on the
practice- focused question, sources of evidence, evidence generated for the doctoral
project and procedures that were used for the collection and analysis of evidence.
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Section 3: Collection and Analysis of Evidence
Introduction
At a hospice office located in South Carolina, during the admission process, the
same pain management treatments are prescribed for everyone, regardless of diagnosis.
CPG and EBP in this setting have not been employed for pain management. This project
answered the following practice-focused question:
PFQ: In the context of hospice, what are current evidence-based strategies for
managing pain?
In Section 3, I focus on the practice focused question, sources of evidence,
evidence generated for the doctorate project, and procedures that I used for the collection
and analysis of evidence. In hospice care, most patients are treated with the same pain
management regimen, and their pain is not effectively controlled (Booker & Haedtke,
2016). According to Booker and Haedtke (2016), EBP is not widely used in hospice. Not
only is this not patient-centered, but for a patient to be in pain at the end of life is
unethical. According to current evidence-based research, pain in hospice patients is a
growing problem (Chi et al., 2018).
Practice-Focused Question
This project answered the question:
PFQ: In the context of hospice, what are current evidence-based strategies for
managing pain?
The gap in nursing practice was evident as current clinical guidelines and EBP
had not been updated properly for pain management in this setting. More specifically, the
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gap in practice that this CPG will correct is that not all patients are receiving adequate
end-of-life pain management. The challenge is to assist in achieving adequate pain
management for patients at the end of life to ensure that they are receiving effective pain
management based on individual need. This updated CPG improves the patient’s clinical
course, improves patient quality of life, eases caregiver stress, and improves overall
satisfaction in providing services for the patient and family. This will be done by filling a
void in the current practice for addressing pain management in this facility. When a
person is entering the last days of life in hospice care, communication, and shared
decision-making with the dying person and those important to them should not have to be
about pain management. Pain management, pain medicine, pain control or alleviation is a
branch of medicine that uses an interdisciplinary approach for easing suffering and
improving the quality of life of those living with pain (Raffaeli & Arnaudo, 2017).
I collaborated in developing updated CPG using evidence-based research and
helped create new clinical models for pain management in the hospice patient population.
I updated the clinical guidelines to allow prescription pain medication to be based on the
clinical diagnosis information from admission instead of using standing orders. Effective
pain management requires the intervention of all disciplines in a holistic approach.
Unrelieved pain affects the patient's physical, psychological, social, and spiritual wellbeing. According to the National Institute of Health (2021), more that 1.6 million
Americans received hospice services in 2014, and approximately 60% of them received
these services at home. Hospice care emphasizes the deployment of an interdisciplinary
care team to support patients and their family in comfort care, pain control, symptom
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management, and spiritual needs. Chi et al (2018) has found that the patients’ pain was
undertreated in end-of-life care.
Sources of Evidence
The literature suggested that updated CPG will provide better outcomes in pain
management for end-of-life care (Herr et al., 2015). An updated CPG was produced by
accessing major databases including Google Scholar, the New England Journal of
Medicine, PubMed, CINAHL, and Scopus. Specific sources of evidence that were
searched included books, dissertations, theses, peer-reviewed journals, and random
controlled trials. The year range that I researched were the last 10 years, 2010-2020. The
reason I used this time frame is that it provided the most up to date evidence-based
information. The keywords that I utilized in my search included pain management,
hospice, end of life, pain control, and clinical practice guidelines. Along with a thorough
literature review, I also reviewed and analyzed past CPGs in the hospice pain
management setting.
In the past 10 years, there have been no solid foundational updates in pain
management for end-of-life care. While there are many articles and sources that address
the need for pain management at end of life, there have been few published guidelines.
An article published by Herr et al. (2015) states that the most important goal of hospice
care is a pain-free death. Although pain outcomes are managed more effectively in
hospice than nonhospice settings, there are gaps and inconsistencies in hospice practices
of effective assessment and management of pain (Raffaeli & Arnaudo, 2017). These
inconsistencies are associated with facilities not using CPG in managing pain.
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Implementation of CPG would help update health care providers on effective pain
management strategies in the hospice population. Even high-quality hospice care fails to
eliminate pain in up to 75% of cases (Chi et al., 2018). This lapse in practice is due to
outdated EBP and inconsistencies in using clinical guidelines. For older adults with
cancer, the percent of patients receiving effective pain management without a diagnosis
of cancer remains low (Chi et al., 2018). The degree of variability in pain management
practices are evidenced by low adherence to some pain related EBPs. Those variabilities
encountered among the research suggest other processes of care may lack uniformity.
The relationship between the evidence and the need for updated CPGs are shown
in the most recent 10 years. Medical science is forever changing; this means that an
article published more than 10 years ago may now be obsolete. I wanted to keep this
literature review current by using the most up to date science and evidence. The purpose
of this evidence was to view where the gap in practice was in pain management so that I
could create the most current CPG, one that addressed the practice question. By
collecting data, the project team able to see the exact methodology of pain management
currently in use, how pain regimens are determined based on standing orders, and how
best to implement changes to increase pain control for hospice patients. Collecting and
analyzing this evidence was critical in providing the best up to date information available
for current EBP. Utilizing this evidence was paramount in creating an effective CPG that
addressed the practice problem.
Approval was received from the facility and from Walden’s IRB (approval
number 08-11-21-024132), and evidence-based findings on current approaches for
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managing pain at end of life were collected and analyzed from the medical directors,
nurse practitioners, and other members of the health care team. Collection and analysis of
this evidence provided the most appropriate strategy to address the practice focused
question.
Analysis and Synthesis
As stated previously, the practice problem occurring in this clinical setting is pain
management orders that are outdated and underemployed for terminally ill patients
admitted for hospice care. Adopting a CPG as an approach, this DNP project was
designed to answer the following practice-focused question:
PFQ: In the context of hospice, what are current evidence-based strategies for
managing pain?
Major steps for developing the CPG included selection of current evidence, searching the
literature, critically appraising and synthesizing the literature, and developing the CPG.
Following development of the CPG, an expert panel was asked to review and score the
CPG. Using feedback from the panel, the CPG was revised as needed. The final steps in
developing the CPG included seeking key stakeholder input and finalization of the CPG.
The content that follows provides details of the procedure that was used to analyze and
synthesize evidence that was utilized to answer the practice-focus question.
Collected data was tracked, organized, recorded, and analyzed using Microsoft
Word, Microsoft Excel, Fulcrum, GRADE , AGREE II, and Mum’s Hummingbird
software. Maintaining the integrity and safety of the evidence was paramount to the
investigation. By precisely using the data integrity software suite Fulcrum, the team was
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sure that the integrity of the evidence collected was thoroughly examined for outliers and
missing information. These systems were double and triple checked for accuracy,
integrity, and completeness. Data analysis was conducted using the AGREE II instrument
(http://www.agreetrust.org); I analyzed each of the six domain scores and overall
assessment of the clinical practice guideline. After this step was completed, the final
score was calculated and reported.
The AGREE instrument evaluates the process of practice guideline development
and the quality of reporting. The AGREE tool (Appendix A) comprises 23 items (each
with specific reporting criteria) in six domains: Scope and Purpose (Items 1-3),
Stakeholder Involvement (Items 4-6), Rigor of Development (Items 7-14), Clarity of
Presentation (Items 15-17), Applicability (Items 18-21), and Editorial Independence
(Items 22-23). An additional two-question “overall guideline assessment” asks the expert
panelist to judge the overall quality of the guideline and indicate whether the guideline
should be recommended for clinical practice. The original AGREE instrument was
developed in 2003 and refined resulting in the AGREE II instrument. Authors of practice
guidelines can use the AGREE Reporting Checklist prospectively during the drafting and
final editing stage to ensure that all necessary information is included and retrospectively
after the guideline is completed as a quality assurance step. The AGREE Reporting
Checklist (Appendix C) is sufficiently universal that it can be used by practice guideline
stakeholders regardless of the more specific protocols or methods used to support the
development of the guidelines.
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GRADE is a transparent framework for developing and presenting summaries of
evidence and provides a systematic approach for making clinical practice
recommendations (Guyatt et al, 2008). It is the most widely adopted tool for grading the
quality of evidence and for making recommendations, with over 100 educational
organizations worldwide officially endorsing GRADE. GRADE has four levels of
evidence, also known as certainty in evidence or quality of evidence: very low, low,
moderate, and high (Table 1).
Table 1
Grade Certainty Ratings
Very low
Low
Moderate
High

The true effect is probably markedly different from the
estimated effect
The true effect might be markedly different from the estimated
effect
The authors believe that the true effect is probably close to the
estimated effect
The authors have a lot of confidence that the true effect is
similar to the estimated effect

Evidence from randomized controlled trials starts at high quality and, because of
residual confounding, evidence that includes observational data starts at low quality. The
Grade of the evidence is included in the literature review in Appendix D.
There are different ways to classify studies that evaluate health care services. One
such scheme distinguishes between process and outcomes studies (Chi,2018). Process
studies are what science uses to assess whether the medical care encounters constitute
quality care. Analysis will be performed on all the data, to track and trend all the
information. This analysis helped us determine where current CPGs have failed, and how
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an updated CPG can be more beneficial, which will answer the practice focused question.
The DNP student has updated the CPG based on current evidence. After the clinical
practice guideline was updated, the student sought consent from panelists. The consent
asked for them to participate on the expert panel to provide feedback and
recommendations. These experts included the facility medical director and nurse
practitioners, who will be the most involved in the hospice patient’s pain management
protocols.
Selection of Evidence and Searching the Literature
A literature search was conducted to locate current evidence for managing pain in
the hospice population. Using the assistance of the university library liaison, major
databases were searched including Google Scholar, PubMed, CINAHL, EMBASE,
TOXNET and Cochrane Library. Evidence selected for the CPG was analyzed,
organized, and recorded using a literature summary table (Table 2, Appendix D)
Table 2
Literature Summary Table Example
Author /
publication year

Type of
source

Population /
sample

Intervention

Findings
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Critical Appraisal of the Evidence from the Literature
GRADE was used to critically appraise the evidence selected for inclusion in the
CPG. GRADE is a transparent framework for developing and presenting summaries of
evidence and provides a systematic approach for making clinical practice
recommendations. It is the most widely adopted tool for grading the quality of evidence
and for making recommendations. I have also followed Walden Universities guideline for
CPG development.
Synthesis of Evidence from the Literature
Synthesis of the evidence was presented to expert panelists using a concept map,
literature table and narrative summary explaining current evidence in managing pain in
the hospice population.
Development of the Clinical Practice Guideline
The CPG includes recommendations that were based on evidence from a rigorous
systematic review and synthesis of the published medical literature found for this topic.
The clinical practice guideline was developed based on an analysis and synthesis of the
literature on current practices for managing pain in the hospice population. Once all the
literature had been reviewed, and the expert panel consulted, the updated CPG was
created and then evaluated and approved by the experts and the stakeholders.
Expert Panel Review
Using the AGREE II Instrument (Appendix A), and the AGREE II scoring
checklist (Appendix C) the CPG was reviewed by an expert panel. The panel scored the
CPG by reviewing all the data and giving a rating of very low, low, moderate, or high on
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the usefulness and completeness of the CPG via GRADE. The expert panel was asked if
the CPG meets their expectations, does not meet expectations, or exceeds expectations.
The expert panel was then be asked if they will be comfortable or not comfortable
implementing the CPG into their practice. This process helped the writer determine if the
CPG meets the needs and expectations of the stakeholders and expert panelists. At the
completion of the DNP project, an evaluation was performed. The summary of the
evaluation consisted of the AGREE II scores, and recommendations for use and
implementation. This data was presented to the content experts for evaluation and
provided to the facility stakeholders for review and implementation consideration.
Stakeholder Input
The stakeholders for this updated CPG were the health care workers and health
care providers. These individuals were the nurses, physicians, nurse practitioners,
physician assistants and all other clinical staff that work in patient care. Input on this
updated CPG was obtained from the clinical team, (nurses, nurse practitioners, aids, and
support staff) who assisted in advising on the necessity and usefulness of the proposed
update. These front-line staff are the individuals who are hands on with the patients and
see the need for change daily. The input from these staff members was paramount to the
success of the updated CPG. Input and recommendations by these teams provided
assurance that patient needs are met. These staff members know from personal
experience, clinical practice and from patient and family input, exactly what is needed to
provide effective pain management.
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Protection of Participants
After I obtained proposal approval, I submitted the project to Walden’s IRB for
review and approved. The Walden IRB role was to review the project for any potential
human subject violations or any breaches in data collection in accordance with Walden’s
regulations. Following the approval from Walden’s IRB, the project was submitted to the
project site for review and approval. The role of the project site was to ensure the project
complies with the organization’s research requirements and human subject protections.
Finalization of Clinical Practice Guideline
This section summarizes the development process by reviewing key literature
from other CPG developers. It focused on key methods and challenges specific to CPGs
for integration by using analysis and synthesis to provide a powerful update to this CPG
development. The guideline development process identified, together with new
approaches, incorporated evidence-based methodology and provided more up to date
information for hospice patients. It is also believed that quality of life issues based on
pain levels were not fully addressed in prior guidelines. Information to finalize the CPG
was used from shared experiences and coping strategies that empower nurses to take
charge of their patient’s pain management and become equal partners with other care
providers.
Summary
In section three, we reviewed the practice focused question and sources of
evidence. We described the procedures we will be using for tracking and processing the
data, protecting the integrity of the evidence, and processing the data. We talked about
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analysis procedures and how they helped to answer the practice focused question. Section
three also included details of the systems for data analysis and synthesis. Procedures for
collection and analysis of evidence to answer the practice focused question were
discussed. Section three also presented plans to address human subject protection. In
section four, we will discuss findings and implications, contributions of the doctoral
team, strengths and limitations, recommendations, and contributions of this project.
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Section 4: Findings and Recommendations
Introduction
The local problem that was addressed in this project was that hospice patients’
pain management was not being met using the previous protocols. This was prohibiting
the clinical staff from providing the best end-of-life care possible. Updated standardized
guidelines on end-of-life pain management will bridge the gap to improve pain control.
The newly updated CPG serves to answer the practice focused question:
PFQ: In the context of hospice, what are current evidence-based strategies for
managing pain?
The gap in nursing practice was addressed by creating an updated CPG for hospice
clinicians to use for better pain management during hospice care. This updated CPG will
provide prescribing information to providers so they can provide quality pain
management and treatment to hospice patients. This will provide a better standard of care
as well as increased quality of life and improved patient outcomes.
Using Walden’s library, I utilized peer reviewed articles from Cochrane Database,
PubMed, Google Scholar, PubMed, CINAHL, EMBASE, and Medline to address the gap
in practice and update the CPG. This review was exhaustive and critical for organizing
the evidence for the updated CPG. Following the AGREE II guidelines, I was able to
create the updated CPG for end-of-life pain management for hospice patients. The CPG
was assessed by an expert panel consisting of five clinicians, who used the AGREE II
website. The data was then scored for each of the domains. These numbers were then
imported confidentially, hiding any identifying characteristics and maintaining the
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experts’ confidentiality. In section 4, I discuss the findings, strengths, and limitations of
this project.
Findings and Implications
The literature that were applicable were all graded using the GRADE
methodology (Table 1) to evaluate the strength and quality of support to the
recommendations in the guideline. The GRADE methodology applies a cohesive and
organized approach, which is used to determine the strength and direction of
recommendations. The strength of each piece of evidence was assigned a grading level of
very low, low, moderate, and high. Each piece of evidence was synthesized into an
evidence table to manage the evidence The guideline was created using the graded
evidence that supported the recommendations. Only articles that scored as high or
moderate on the GRADE scale were used in the final determination for this updated
CPG. Articles that scored a level of low or very low were excluded. A literature table
with a GRADE score for each article is in Appendix D.
Five expert panelists used the AGREE II tool to provide me with an evaluation of
the updated CPG (Appendix E). The results of the tool showed data from each of the 23
items, as well as six individual domains with a tabulated percentage within each of the
domains. Per the AGREE II tool, Any of the domains that scored higher than 50% were
considered to be acceptable; however any of the domains that scored below 75% should
be further reviewed.
•

Domain I, Scope and Practice, scored a 97%. Domain 1 addressed the CPG
scope and overall focus. The population for this area was admitted hospice
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patients. Evaluator 2 suggested changing the verbiage to include patients
being evaluated for admission and include them in the scope as well. This was
fitting as most of the orders are used on admission.
•

Domain II, Stakeholder Involvement, scored a 98%. The expert panel was
pleased that the guidelines utilized all the appropriate disciplines, such as
physicians, nurse practitioners, physician assistants, and advanced practice
nurses who can prescribe medications. The panel agreed that the stakeholder
involvement domain was clearly defined and that the criteria were met.

•

Domain III, Rigor of Development, scored a 97%. This domain focused on the
methods that were utilized to search for evidence, the criteria for including
evidence, strengths and limitations of the evidence, and the procedures used to
update the guideline. The expert panel agreed that there was enough
supporting evidence and that the literature review was adequate.

•

Domain IV, Clarity of Presentation, scored a 94%. This domain addressed the
clarity of the presentation, which included recommendations and management
of the health issue.

•

Domain V, Applicability, scored a 100%. This domain addressed the
applicability of the guideline, which focused on adequate pain management
for hospice patients using the patient’s diagnosis as a guide instead of standing
orders. The expert panel agreed that this is a very important issue, which
needed to be addressed. The expert panel commented that by using this
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guideline for starts of care, pain management can be controlled from the
beginning and the patient’s quality of life improved overall.
•

Domain VI, Editorial Independence, scored a 95%. There were no funding
requirements for this project. This showed that there were no other views that
would have had competing interest in this guideline. The expert panel agreed
that “funding bodies should not have any influence on guideline
developments.”

•

The overall domain scored was 100%, a usable CPG. In the overall guideline
assessment portion, the expert panel agreed across the board, with all
evaluators agreeing that they would recommend this CPG. Panelists noted that
the guidelines were of “high quality” and come at a time where they could not
be more needed in the hospice community. The panel agreed that these
guidelines would increase patients’ quality of life, improve pain management,
advance positive patient and family outcomes, and reduce the stress on the
clinical team. Considering that these guidelines come with no additional cost
to the facilities or community, there are no financial burdens to deter the
guidelines from use.
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Table 3
AGREE II Scores Compilation
Evaluator

Domain Domain Domain Domain Domain Domain Overall
1

2

3

4

5

6

guideline
assessment

1

21

20

56

21

28

14

7

2

21

21

54

20

28

13

7

3

20

21

55

19

28

13

7

4

20

21

54

19

28

13

7

5

20

20

55

20

28

14

7

98%

97%

94%

100%

95%

100%

Percentage 97%

Note. Threshold for guideline quality is 70% or above.
I was gratified to see such high scoring results for this updated CPG from the
expert panel. None of the expert panelists asked for additional information or
clarification. All commented that it was a well thought out and presented CPG and very
usable in the practice setting. When presenting the results and discussing all the scores
with the experts, they were impressed with the thoroughness, thoughtfulness, ethical
consideration, and quality of life improvement that would render the updated CPG
beneficial. No changes or updates were recommended by any of the experts during the
review. All expert panelists strongly encouraged that the updated CPG be implemented as
soon as possible and shared with the other facilities in the community and throughout the
company. They are hopeful for a streamlined implementation with continuity of care
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throughout the different levels of the health system. The feedback from all other end
users of the CPG were that overall, this was a very well written and beneficial CPG and
will indeed assist in an increased quality of life for the hospice patient due to improved
pain management. The updated CPG will give the clinicians the tools to ensure that
correct pain medications are ordered on admission based on clinical diagnosis and not
standing orders. Admissions of different diagnoses require different care. As shown in the
chart below, cancer patients make up 65% of admissions, heart disease 20%, dementia
10%, and other natural causes 5%. Each of these different types of patients needs a
different care plan and requires different pain management techniques.
Figure 1
[Provide a figure caption here in italics and title case, and add it to the List of Figures]

Cancer
Heart Disease
Dementia
Nstural Cuases

Recommendations
The gap in nursing practice was addressed by creating an updated CPG for
hospice clinicians to use for better pain management during hospice care. This CPG
directs the hospice practitioners to utilize the patient’s diagnosis instead of standing
orders for pain control, which will result in better pain management at admission. The
expert panel and I recommend that the hospice nurses, clinicians, and practitioners use
this updated evidence-based pain management guideline to prescribe pain medications.
The expert panel and I recommend that the guideline move forward for review for the
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specific approvals required by the facility at the corporate level, that the nurses be
adequately educated and trained in the updated CPG, and that the results be monitored to
determine the effectiveness of the guideline on quality of life and pain control. This
updated CPG will provide prescribing information to providers so they can provide
quality pain management and treatment to hospice patients. This will provide a better
standard of care as well as increased quality of life and improved patient outcomes. The
expert panel recommended that the updated CPG be incorporated into policy and added
to the clinician's admission packet under pain management guidelines. Implementing this
updated CPG will constitute an innovative approach using the multidisciplinary team,
which will create a culture of improved quality of care and social change.
This CPG adoption will help nurse practitioners and physicians provide early
adequate pain management that will address the patients' needs by using their diagnosis
as a guide, incorporated with standard pain scales. The project plan is for the proposed
CPG update to be introduced to the facility administration for implementation to the local
facility, as well as, potentially, other hospice facilities.
Strengths and Limitations of the Project
This updated CPG's positive aspects include that the expert panel of hospice
clinicians were already familiar with the need for updated pain guidelines. This gave the
clinicians a chance to incorporate their research findings into recommendations for the
CPG update. Having the expert panel of devoted and qualified professionals ready to
participate made the transitions from research to creation smooth. These
recommendations strengthened the updated CPG and incorporated these suggestions into
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a strong clinical guide. Another strength of this project is the opportunity for it to be
applied to any clinical environment that care for hospice patients. There are many
hospices in each state. Some of these are incorporated into home care, hospitals, and
nursing homes. If these facilities adopt this updated CPG, the continuity of care across
the spectrum for these patients would be seamless. Many times, hospice patients are
moved to different facilities outside of their home area. By getting this updated CPG
adopted in multiple areas, or potentially multiple states, this would make for a pain free
transition. There is always a need for better pain management, especially at the end of
life. This updated CPG would benefit any hospice location and provide much needed
guidance for the patients we serve. This updated CPG provides a pathway of appropriate
pain management for any provider in any location. An additional strength to the project is
its alignment to the current changes in the healthcare delivery system. The worldwide
interest in the development and implementation of patient-centered model of care,
management of pain, and incorporation of evidence into practice to improve patient care
outcomes and quality of life in hospice.
Limitations I faced while preparing this updated CPG were the facility COVID
restrictions. This made it difficult to meet with the clinical team and expert panels at the
same time. Many work arounds had to be made to facilitate the meetings, suggestions,
questions, and concerns about the CPG. It also made it difficult to gain access to the
facility at times, to perform research in a timely manner. Another limitation was that
since the patients are hospice patients, and most are at the end of life, supporting
documentation for pain management was found to be lacking. This is mainly due to the
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patient's life expectancy was shorter than traditional patients due to the nature of the
specialty. There was also no CPG that clearly addressed pain management based on
patients' diagnosis at admission, that I could refer to. Further, misuse of techniques by
nursing staff due to inadequate monitoring and training in pain assessments can
negatively affect the outcomes of the project. This happens when you have new staff or
temporary staff nurses who are not consistent with their assessment or reporting
techniques, such as travel nurses in nursing facilities.
Contribution of the Doctoral Project Team
An expert panel was assembled for review and assessment of the updated CPG.
This panel included experts in the hospice industry and include two hospice medical
directors, two hospice nurse practitioners and one clinical nurse specialist. These
panelists are responsible for monitoring and prescribing the pain management regimens
in the hospice population. The purpose of this project was to develop an evidence-based
pain management updated clinical practice guideline to be used in the hospice
setting. The expert panel reviewed the CPG using the Agree II tool. Domains 1 through 6
were reviewed and applied to the tool. Under each domain, all members of the team
strongly agreed with the recommendations. This project was fully supported by the five
members of the panel. The nursing staff and other clinical staff including the nursing
director and supervisors, also reviewed the project and are fully supportive of the project
and are awaiting approval to implement the updated CPG.
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Summary
The updated CPG development for pain management was addressed in this
section. The main strength of this project was an ability to research and define relevant,
up to date, peer reviewed literature which was utilized to update the CPG. These research
findings were provided by the expert panelists who are one of the main stakeholders in
this CPG. The main limitation of this study was a lack of previous CPG's which
addressed the need of pain management guidelines based on diagnosis. The expert panel's
AGREE II evaluation recognized the quality and appropriateness of the updated CPG,
which was recommended for implementation at the facility and regional level. Besides a
reduction in the health care costs, proper pain management programs assist with
decreasing demand on healthcare services. Effectiveness in pain management can
promote quality of life, improved understanding of pain mechanisms, and exposure to
different treatment options available for managing end-of-life pain. In section 5, I will
address my plan for dissemination as well as the analysis of myself.
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Section 5: Dissemination Plan
The plan is for the newly updated CPG for pain management for hospice patients
to be introduced to facility administration for review and implementation. There is more
than one location that could benefit from implementing this CPG. Once it proves
successful at the pilot location; it can be transferred for use to the other locations in and
out of the state. My hope is that once it shows success, this updated CPG will be adopted
by other hospice offices, nursing homes, and hospice in-patient facilities. This will
provide seamless care for all patients, regardless of their acuity level, state of residence,
or diagnosis. My plan for dissemination beyond the target location is to have the updated
CPG published to a respectable journal such as Walden University’s Journal of
Excellence in Nursing Healthcare Practice or the American Journal of Hospice and
Palliative Medicine. The American Hospice journal has a robust platform with a
population of professional nurses, advanced practice nurses, and hospice physicians who
work in the field of hospice care where pain management is priority.
Analysis of Self
I started my nursing career as a licensed practical nurse in Pittsburgh,
Pennsylvania. I found my passion in geriatric care almost immediately. Most of my
tenure as a new nurse was on the front lines in skilled nursing, where I had many hospice
patients. I found it my obligation to learn more about managing elderly patients so I could
provide the best care possible. This sense of duty led to the completion of registered
nursing education as an associate degree nurse (ADN). I knew if I were to continue my
pursuit of being an advanced practice nurse, I needed to have more education and a better
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foundation. I then decided to go on for my bachelor’s in nursing. I found this was still not
enough to be in a position of advanced leadership where I could make a difference in
nursing practice and patient care. I worked my way up in the clinical setting from a
bedside nurse to a nurse manager to a director of clinical care to director of nursing. I had
my sights set on being a chief nursing officer and knew I again needed to advance my
nursing education. To teach one day, I started the Master of Nursing Education program
and graduated from Walden University. I immediately enrolled in the DNP program
where I am today. I have completed my lifelong dream of having a terminal degree in
nursing and am the first nurse in my family to have such a title. Nursing is my passion; I
love being a leader, a clinician, and a patient advocate. I love being in a position where I
can make a difference in patient care by having influence in policy. Working toward a
DNP taught me how to research and apply evidence into policy creation for staff,
patients, and practitioners. Choosing to update a CPG, I found that I could give the art of
evidence-based pain management back to the field and patient population I love.
As a Practitioner
As an advanced practice nurse working both at the beside and as a nursing
director, I was able to see firsthand the practice problem and gap in nursing practice. My
drive to continue bedside clinical practice has allowed me to understand the issues
needing attention in the practice specialty. As an advanced practice nurse, I have worked
with diverse hospice patient populations with different diagnoses requiring pain
management. Early pain management techniques enable the patient and family to have an
increased quality of life and better outcomes. After the experiences that this CPG has
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provided, it is very clear that nurse and physician education in the art of pain
management is essential. There is a lack of DNP prepared hospice nurses in this
specialty, and most of those do not work directly in patient care. By utilizing the
education that my DNP has provided me, I will be able to serve my patients firsthand
both at the bedside and at the policy level.
As a Scholar
The DNP project has provided to me the tools and insight to provide
demonstrated knowledge focused on a particular field. The DNP project plays a very
important role in terminal education and encourages the student to be involved in
academic and clinical practice through research. This project set a path for me to continue
to contribute to the nursing profession through research and development. I intend to
continue scholarly contributions to the nursing profession as my career grows so that I
can share my knowledge of clinical and academia practices with my health care team.
The DNP essentials that provided my platform and knowledge base for the DNP project
will continue to mold my scholarly thinking and future contributions to nursing practice.
As a Project Manager
As the project manager for the updated CPG, I was fortunate to be able to
collaborate with a dedicated and compassionate group of experts who offered their
invaluable insight and expertise. Their recommendations on the CPG helped to guide me
in the right direction and provide a more detailed and focused update for hospice pain
management. I found that this expert panel was excited to assist and complete the
AGREE II tool. It was my responsibility for providing the expert panel with the tools to
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complete this task, such as the AGREE II instrument, the CPG, the Literature review
matrix, and the panelist disclosure form. As the project manager, I was able to
successfully manage these tasks. The expert panelists, who are all hospice clinicians,
were excited to have an updated CPG tailored to their specialty. This project had its
stressful points, but I have found it very rewarding. Knowing that the end results will be
implemented to reduce pain in fragile hospice patients and increase their remaining
quality of life made everything worthwhile.
Challenges, Solutions, and Insights Gained
During this project, I faced both personal and academic challenges. Time
management and procrastination seemed to always be an issue, especially with the added
challenge of COVID to my practicum setting. Challenges were further exaggerated with a
full-time nursing manager position and a family with a very active schedule. The
academic trials I faced were using the research tools that were new to me. AGREE II was
also a new tool that I had to learn to use and score based on its design. My mentor was
very helpful in motivating me in the right direction and pushing me to completion. I knew
when I was at a crossroads that she would be my guide. The project development process
has increased my understanding of research and helped to mold my competency in
translating theory into research and evidence. It was through being mentored for this
guideline that I also learned how to mentor others who were new to EBP theory. With my
educational advancements, I can continue to be an agent for social change in the nursing
field. By creating an updated CPG, I have also learned how invested a person must
remain and how many steps are involved in achieving organizational change.
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Summary
For this DNP scholarly project, I developed an updated clinical practice guideline
that addresses pain with hospice patients. This addresses the gap in practice identified in
Section 1, which states that hospice patients are all receiving the same standing orders for
pain management despite their different diagnoses. This project promotes positive social
change by allowing patients and families to focus on improving their quality of life
during their remaining time together and not having to worry about the patient’s pain
being managed appropriately. Because patient centered care is a priority in clinical
practice, it is the duty of a nursing professional is to provide the best care possible for the
patient’s condition. This updated CPG should improve quality patient care, reduce
patients’ end-of-life pain, increase quality of life, and provide patient-centered care to this
vulnerable population. By having this updated CPG as a guide, clinicians will be able to
prescribe pain management on admission that is appropriate based on the diagnosis of the
patient. This updated CPG will also serve to increase the clinical staff’s knowledge,
increase overall satisfaction with hospice care, and improve the quality of the services
provided.
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Appendix A: AGREE II Score Sheet

AGREE II Rating
Domain

Item

1
Strongly
Disagree

Scope and
purpose

Stakeholder
involvement

Rigor of
development

1.

The overall objective(s) of the
guideline is (are) specifically
described.

2.

The health question(s) covered by the
guideline is (are) specifically
described.

3.

The population (patients, public, etc.)
to whom the guideline is meant to
apply is specifically described.

4.

The guideline development group
includes individuals from all the
relevant professional groups.

5.

The views and preferences of the
target population (patients, public, etc.)
have been sought.

6.

The target users of the guideline are
clearly defined.

7.

Systematic methods were used to
search for evidence.

8.

The criteria for selecting the evidence
are clearly described.

9.

The strengths and limitations of the
body of evidence are clearly
described.

10. The methods for formulating the
recommendations are clearly
described.
11. The health benefits, side effects and
risks have been considered in
formulating the recommendations.
12. There is an explicit link between the
recommendations and the supporting
evidence.
13. The guideline has been externally
reviewed by experts prior to its
publication.
14. A procedure for updating the guideline

2

3

4

5

6

7
Strongl
y Agree
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AGREE II Rating
Domain

Item

1
Strongly
Disagree

2

3

4

5

6

2

3

4

5

6

7
Strongl
y Agree

is provided.
Clarity of
presentation

15. The recommendations are specific and
unambiguous.
16. The different options for management
of the condition or health issue are
clearly presented.
17. Key recommendations are easily
identifiable.

Applicability

18. The guideline describes facilitators and
barriers to its application.
19. The guideline provides advice and/or
tools on how the recommendations
can be put into practice.
20. The potential resource implications of
applying the recommendations have
been considered.
21. The guideline presents monitoring and/
or auditing criteria.

Editorial
independenc
e

22. The views of the funding body have
not influenced the content of the
guideline.
23. Competing interests of guideline
development group members have
been recorded and addressed.

Overall
Guideline
Assessment

1.

Rate the overall quality of this
guideline.

Overall
Guideline
Assessment

2. I would recommend this guideline for
use.

1
Lowest
possible
quality

7

Yes

Yes, with
modificati
ons

Highest
possible
quality

No
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Appendix B: Levels of Evidence

Level 1 - Systematic review & meta-analysis of randomized controlled trials; clinical guidelines
based on systematic reviews or meta-analyses
Level 2 - One or more randomized controlled trials
Level 3 - Controlled trial (no randomization)
Level 4 - Case-control or cohort study
Level 5 - Systematic review of descriptive & qualitative studies
Level 6 - Single descriptive or qualitative study
Level 7 - Expert opinion

Modified from:
Melnyk, B.M. & Fineout-Overholt, E. (2015). "Box 1.3: Rating system for the hierarchy of
evidence for intervention/treatment questions" in Evidence-based practice in nursing &
healthcare: A guide to best practice (3rd ed., p. 11). Wolters Kluwer Health.
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Appendix C: Agree Reporting Checklist

AGREE Reporting Checklist
2016
This checklist is intended to guide the reporting of clinical practice
guidelines.

CHECKLIST ITEM AND
DESCRIPTION

REPORTING CRITERIA

Pag
e#

DOMAIN 1: SCOPE AND PURPOSE
1. OBJECTIVES
Report the overall objective(s) of
the guideline. The expected health
benefits from the guideline are to
be specific to the clinical problem or
health topic.
2. QUESTIONS
Report the health question(s)
covered by the guideline,
particularly for the key
recommendations.
3. POPULATION
Describe the population (i.e.,
patients, public, etc.) to whom the
guideline is meant to apply.

Health intent(s) (i.e., prevention,
screening, diagnosis, treatment, etc.)
Expected benefit(s) or outcome(s)
Target(s) (e.g., patient population,
society)
Target population
Intervention(s) or exposure(s)
Comparisons (if appropriate)
Outcome(s)
Health care setting or context
Target population, sex, and age
Clinical condition (if relevant)
Severity/stage of disease (if relevant)
Comorbidities (if relevant)
Excluded populations (if relevant)

DOMAIN 2: STAKEHOLDER INVOLVEMENT
4. GROUP MEMBERSHIP
Report all individuals who were
involved in the development
process. This may include
members of the steering group, the
research team involved in selecting
and reviewing/rating the evidence
and individuals involved in
formulating the final
recommendations.
5. TARGET POPULATION
PREFERENCES AND VIEWS
Report how the views and
preferences of the target population
were sought/considered and what

Name of participant
Discipline/content expertise (e.g.,
neurosurgeon, methodologist)
Institution (e.g., St. Peter’s hospital)
Geographical location (e.g., Seattle,
WA)
A description of the member’s role in
the guideline development group

Statement of type of strategy used to
capture patients’/publics’ views and
preferences (e.g., participation in the
guideline development group, literature
review of values and preferences)

o
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the resulting outcomes were.

6. TARGET USERS
Report the target (or intended)
users of the guideline.

Methods by which preferences and
views were sought (e.g., evidence from
literature, surveys, focus groups)
Outcomes/information gathered on
patient/public information
How the information gathered was
used to inform the guideline
development process and/or formation
of the recommendations
The intended guideline audience (e.g.,
specialists, family physicians, patients,
clinical or institutional
leaders/administrators)
How the guideline may be used by its
target audience (e.g., to inform clinical
decisions, to inform policy, to inform
standards of care)

DOMAIN 3: RIGOUR OF DEVELOPMENT
7. SEARCH METHODS
Report details of the strategy used
to search for evidence.

8. EVIDENCE SELECTION
CRITERIA
Report the criteria used to select
(i.e., include and exclude) the
evidence. Provide rationale, where
appropriate.
9. STRENGTHS & LIMITATIONS
OF THE EVIDENCE
Describe the strengths and
limitations of the evidence.
Consider from the perspective of
the individual studies and the body
of evidence aggregated across all
the studies. Tools exist that can
facilitate the reporting of this
concept.

Named electronic database(s) or
evidence source(s) where the search
was performed (e.g., MEDLINE,
EMBASE, PsychINFO, CINAHL)
Time periods searched (e.g., January
1, 2004, to March 31, 2008)
Search terms used (e.g., text words,
indexing terms, subheadings)
Full search strategy included (e.g.,
possibly located in appendix)
Target population (patient, public, etc.)
characteristics
Study design
Comparisons (if relevant)
Outcomes
Language (if relevant)
Context (if relevant)
Study design(s) included in body of
evidence
Study methodology limitations
(sampling, blinding, allocation
concealment, analytical methods)
Appropriateness/relevance of primary
and secondary outcomes considered
Consistency of results across studies
Direction of results across studies
Magnitude of benefit versus magnitude
of harm
Applicability to practice context
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10. FORMULATION OF
RECOMMENDATIONS
Describe the methods used to
formulate the recommendations
and how final decisions were
reached. Specify any areas of
disagreement and the methods
used to resolve them.

11. CONSIDERATION OF
BENEFITS AND HARMS
Report the health benefits, side
effects, and risks that were
considered when formulating the
recommendations.

12. LINK BETWEEN
RECOMMENDATIONS AND
EVIDENCE
Describe the explicit link between
the recommendations and the
evidence on which they are based.

13. EXTERNAL REVIEW
Report the methodology used to
conduct the external review.

Recommendation development
process (e.g., steps used in modified
Delphi technique, voting procedures
that were considered)
Outcomes of the recommendation
development process (e.g., extent to
which consensus was reached using
modified Delphi technique, outcome of
voting procedures)
How the process influenced the
recommendations (e.g., results of
Delphi technique influence final
recommendation, alignment with
recommendations and the final vote)
Supporting data and report of benefits
Supporting data and report of
harms/side effects/risks
Reporting of the balance/trade-off
between benefits and harms/side
effects/risks
Recommendations reflect
considerations of both benefits and
harms/side effects/risks
How the guideline development group
linked and used the evidence to inform
recommendations
Link between each recommendation
and key evidence (text description
and/or reference list)
Link between recommendations and
evidence summaries and/or evidence
tables in the results section of the
guideline
Purpose and intent of the external
review (e.g., to improve quality, gather
feedback on draft recommendations,
assess applicability and feasibility,
disseminate evidence)
Methods taken to undertake the
external review (e.g., rating scale,
open-ended questions)
Description of the external reviewers
(e.g., number, type of reviewers,
affiliations)
Outcomes/information gathered from
the external review (e.g., summary of
key findings)
How the information gathered was
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14. UPDATING PROCEDURE
Describe the procedure for
updating the guideline.

used to inform the guideline
development process and/or formation
of the recommendations (e.g.,
guideline panel considered results of
review in forming final
recommendations)
A statement that the guideline will be
updated
Explicit time interval or explicit criteria
to guide decisions about when an
update will occur
Methodology for the updating
procedure

DOMAIN 4: CLARITY OF PRESENTATION
15. SPECIFIC AND
UNAMBIGUOUS
RECOMMENDATIONS
Describe which options are
appropriate in which situations and
in which population groups, as
informed by the body of evidence.

16. MANAGEMENT OPTIONS
Describe the different options for
managing the condition or health
issue.
17. IDENTIFIABLE KEY
RECOMMENDATIONS
Present the key recommendations
so that they are easy to identify.

A statement of the recommended
action
Intent or purpose of the recommended
action (e.g., to improve quality of life, to
decrease side effects)
Relevant population (e.g., patients,
public)
Caveats or qualifying statements, if
relevant (e.g., patients or conditions for
whom the recommendations would not
apply)
If there is uncertainty about the best
care option(s), the uncertainty should
be stated in the guideline
Description of management options
Population or clinical situation most
appropriate to each option
Recommendations in a summarized
box, typed in bold, underlined, or
presented as flow charts or algorithms
Specific recommendations grouped
together in one section

DOMAIN 5: APPLICABILITY
18. FACILITATORS AND
BARRIERS TO APPLICATION
Describe the facilitators and
barriers to the guideline’s
application.

Types of facilitators and barriers that
were considered
Methods by which information
regarding the facilitators and barriers to
implementing recommendations were
sought (e.g., feedback from key
stakeholders, pilot testing of guidelines
before widespread implementation)
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19. IMPLEMENTATION
ADVICE/TOOLS
Provide advice and/or tools on how
the recommendations can be
applied in practice.

20. RESOURCE IMPLICATIONS
Describe any potential resource
implications of applying the
recommendations.

21. MONITORING/ AUDITING
CRITERIA
Provide monitoring and/or auditing
criteria to measure the application
of guideline recommendations.

Information/description of the types of
facilitators and barriers that emerged
from the inquiry (e.g., practitioners
have the skills to deliver the
recommended care, sufficient
equipment is not available to ensure all
eligible members of the population
receive mammography)
How the information influenced the
guideline development process and/or
formation of the recommendations
Additional materials to support the
implementation of the guideline in
practice.
For example:
o Guideline summary documents
o Links to check lists, algorithms
o Links to how-to manuals
o Solutions linked to barrier analysis
(see Item 18)
o Tools to capitalize on guideline
facilitators (see Item 18)
o Outcome of pilot test and lessons
learned
Types of cost information that were
considered (e.g., economic
evaluations, drug acquisition costs)
Methods by which the cost information
was sought (e.g., a health economist
was part of the guideline development
panel, use of health technology
assessments for specific drugs, etc.)
Information/description of the cost
information that emerged from the
inquiry (e.g., specific drug acquisition
costs per treatment course)
How the information gathered was
used to inform the guideline
development process and/or formation
of the recommendations
Criteria to assess guideline
implementation or adherence to
recommendations
Criteria for assessing impact of
implementing the recommendations
Advice on the frequency and interval of
measurement
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Operational definitions of how the
criteria should be measured
DOMAIN 6: EDITORIAL INDEPENDENCE
22. FUNDING BODY
Report the funding body’s influence
on the content of the guideline.

23. COMPETING INTERESTS
Provide an explicit statement that
all group members have declared
whether they have any competing
interests.

The name of the funding body or
source of funding (or explicit statement
of no funding)
A statement that the funding body did
not influence the content of the
guideline
Types of competing interests
considered
Methods by which potential competing
interests were sought
A description of the competing
interests
How the competing interests influenced
the guideline process and development
of recommendations

From:
Brouwers MC, Kerkvliet K, Spithoff K, on behalf of the AGREE Next Steps Consortium. The AGREE
Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 2016;352: i1152. doi:
10.1136/bmj. i1152.
For more information about the AGREE Reporting Checklist, please visit the AGREE Enterprise website at
http://www.agreetrust.org.
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Appendix D: Literature Review
Author/

Type of

Population/

Intervention

Findings

GRADE

Publication

Source

Sample

Booker, S., & Haedtke, C.
(2016). Evaluating pain
management in older
adults. Nursing, 46(6),
pp.66-69.

Publication in
Nursing 2021
peer reviewed
journal

Older adults
presenting to
physician’s
office or
emergency
room

Providing
pain
management
depending on
the level of
pain

Patients who
were treated
quickly with
appropriate
measures did
better with
pain control

Moderate

Carvalho, A., Martins
Pereira, S., Jácomo, A.,
Magalhães, S., Araújo, J.,
Hernández Marrero, P.,
Costa Gomes, C. &
Schatman, M. (2018).
Ethical decision making in
Pain management: a
conceptual
framework. Journal of
Pain Research, Volume
11, pp.967-976.

Publication in
the National
Library of
medicine and
Journal of
Pain
Research

Patients who
were seen for
pain
management
who faced
ethical issues
for
prescribers

Publication in
the American
Journal of
Hospice and
Palliative
Medicine

They
included
baseline
interviews of
15 hospice
caregivers of
patients from
hospice
agencies in
the States of
Washington.
Many of the
participants
were white
and female

Developing
an ethical
framework
for pain
management
will result in
enhanced
quality of
care, linking
the epistemic
domains of
pain
management
to their
anthropologic
al
foundations,
thereby
making them
ethically
sound.
The study
identified 5
out of the 6
major themes
in the original
framework
and
confirmed
that hospice
family
caregivers
face a variety
of challenges:
caregivercentric issues,

Moderate

Chi, N., Demiris, G., Pike,
K., Washington, K., &
Oliver, D. (2018). Pain
Management Concerns
from the Hospice Family
Caregivers’
Perspective. American
Journal of Hospice and
Palliative Medicine®,
35(4), pp.601-611.

describe
possible
ethical
frameworks
that can be
combined and
integrated to
better define
the ethical
issues in pain
management.
and discuss
possible
directions
forward to
improve
ethical
decision
making in
pain
management.
The study
showed that
“Informal
Hospice
Caregiver
Pain
Management
Concerns”
framework is
an applicable
framework
and provided
a
comprehensiv
e

score

Year

High
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caregivers.
They were
spouse/partne
r or adult
child living
with the
patient.

investigation
on hospice
family
caregivers’
difficulties in
pain
management.

National Consensus Project
for Quality Palliative Care.
Clinical Practice
Guidelines for Quality
Palliative Care, 4th edition.
Richmond, VA: National
Coalition for Hospice and
Palliative Care; (2018).
https://www.
nationalcoalitionhpc.org/nc
p.

Clinical
Practice
Guideline

Patients who
were
admitted to
Palliative
care in
Richmond
VA

Provide
updated
clinical
practice
guidelines for
palliative care
patients

Melnyk, B. and GallagherFord, L., (2015).
Implementing the New
Essential Evidence- Based
Practice Competencies in
Real-world Clinical and
Academic Settings:
Moving from Evidence to
Action in Improving
Healthcare Quality and
Patient

Publication in
Worldviews
on Evidence
Based
Nursing

The
healthcare
systems in the
United States
that have
already begun
to implement
the new EBP
competencies
.

There are
very few
validated
tools that
exist to
measure
competency
in EBP. The
three tools
that do exist,
the Berlin
questionnaire,
the Fresno
tool, and the
Assessing
Competency
in Evidence
based
medicine
(ACE) tool,
have focused
on medical
students and

Outcomes. Worldviews
on Evidence-Based
Nursing, 12(2), pp.67-69.

caregiver’s
medication
skills and
knowledge,
communicati
on and
teamwork,
organizationa
l skill, and
patientcentric issues
The NCP
Guidelines
formalize and
delineate
evidencebased
processes and
practices for
the provision
of safe and
reliable highquality
palliative care
for adults,
children, and
families with
serious illness
in all care
settings.
The new
research
based EBP
essential
competencies
provide
leaders with
another tool
that can assist
them in
taking action
and moving
their
organizations
toward high
quality safe
care. They
can be
implemented
in a broad
range of
applications

High

High
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Mularski, R., White-Chu,
F., Overbay, D., Miller, L.,
Asch, S. & Ganzini, L.,
(2010). Measuring pain as
the 5th vital sign does not
improve quality of pain
management. Journal of
General Internal Medicine,
21(6), pp.607-612.

Retrospective
review of
medical
records

Pain
management
patient visits
selected from
all 15 primary
care
providers of a
general
medicine
outpatient
clinic.

Raffaeli, W. & Arnaudo,
E., (2017). Pain as a
disease: an
overview. Journal of Pain
Research, Volume 10,
pp.2003-2008.

Publication in
the Journal of
Pain
Research

A literature
overview of
the several
conceptualiza
tions of pain
as a disease
since the
pioneering
work of John
J Bonica

graduates
from medical
school
retrospectivel
y reviewed
medical
records at a
single
medical
center to
compare
providers’
pain
management
before and
after
implementing
the initiative
and
performed a
subgroup
analysis of
patients
reporting
substantial
pain
10% of the
world’s
population is
affected by a
chronic pain
condition and
every year, an
additional 1
in 10 people
develops
chronic pain.
Pain should
be treated as
a disease and
not a
symptom of a
disease in
chronic
management.

Patients who
reported
substantial
pain often did
not receive
recommended
care: 22%
had no
attention to
pain
documented
in the medical
record, 27%
had no further
assessment
documented,
and 52%
received no
new therapy
for pain at
that visit.

Moderate

acknowledge
d that there is
an essential
difference
between pain
as a symptom
and chronic
pain. The
scientific
community
has also
recognized
the specificity
of Pain as a
disease this
condition
based on the
identification
of several
associated
pathologic
modifications

High
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Appendix E: Clinical Practice Guidelines

Purpose
The purpose of this updated guideline is to provide pain management direction to
the hospice clinical staff during the admission process.
Procedure:
• The CPG will be reviewed with all clinical staff on implementation
• The CPG will be included in new hire orientation
• The CPG will be included in the mandatory annual education for staff
• The CPG will be included in the policy and procedure manual
• The CPG will be used as a guide for prescribing pain medication to
hospice patients being admitted for end-of-life care.
Question
In the context of hospice, what are current evidence-based strategies for managing.
…… .pain?
Target Population
The CPG will be a tool to address pain management during the admission process
………for hospice patients.
Disease/Condition:
All Hospice patients
Guideline Category:
Pain assessment, Pain management, Prevention of unwarranted acute pain;
……...Treatment of acute pain and acute/chronic pain.
General Guidance:
•
•
•
•

Avoid using confusing language, clinical terms, medical jargon
Make the pain assessment your priority on admissions
Do not delegate the pain assessment
Consider having the physician or other clinician with you, or on
the phone standing by to give admission pain orders

Recommendation 1: Numeric pain scaleThe Numeric Pain Scale is to be used on all patients who can speak or respond to
questions and can count to 10, This includes sleeping patients. It is recommended to wake
a patient for a pain assessment to assess for proper pain management effectiveness.
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Propper assessment and documentation on admission is important to follow any trend in
increasing pain, so it can be managed quickly. The numeric pain scale should be utilized
during any additional assessments if the patient remains capable of giving an appropriate
response.

Recommendation 2: Nonverbal pain scaleThe Checklist of Non-verbal Pain Indicators (McGuire, 2016) should be utilized for
nonverbal or non-responsive patients who cannot self-report pain. The CNPI has been
incorporated into most electronic medical record systems in acute and hospice care due to
its usefulness in treating patients who cannot self-report. If this pain scale is not available
on the electronic medical record, a free printable copy is available online. Once this pain
scale is utilized for non-responsive patients, the same scale should continue to be utilized
during each subsequent pain assessment to ensure proper tracking of pain trends.

Recommendation 3: Mild pain treatment by diagnosis
Patients admitted with a diagnosis which would have a “mild” pain rating such as: End
stage cardiac disease with edema less than 2+, failure to thrive, malnutrition, certain pain
free cancers, mild dementia, other end stage disease with mild associated pain, and
admission due to natural causes. These patients should follow pain recommendations for
“mild” pain management.
Acetaminophen extra strength and/or ibuprofen are recommended for mild pain,
acetaminophen is not contraindicated in patients with severe hepatic impairment or those
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at risk for hepatotoxicity in hospice care. Ibuprofen is not contraindicated in hospice
patients with renal disease. Pain management takes priority at end of life. Research shows
that older adults with moderate-to-severe dementia, arthritis and heart disease who take
acetaminophen extra strength routinely have greater levels of general activity and social
interaction than those taking a placebo (McGuire, 2016). All patients should have a
breakthrough gentle opioid medication on board from time of admission. These patients
should also utilize holistic measures for pain management such as: heat or cold therapy,
massage, reiki relaxation, music therapy, touch therapy, aromatherapy, tens therapy and
family presence. An adjuvant medication, such as an antiepileptic drug, antidepressant,
muscle relaxant or anti-anxiety medications could also be useful in these patients before
pain progresses.

Recommendation 4: Moderate pain treatment by diagnosis
Patients admitted with a diagnosis which would carry a “moderate” pain rating such as:
End stage heart disease with 2+ pitting edema or greater, vascular dementia, Alzheimer’s
dementia, fall with mechanical injury and no broken bones, untreatable aneurysm,
Huntington’s disease, moderately metastasized cancers, and similar end stage diseases,
select short acting opioids, with or without acetaminophen and a topical analgesic (for
localized pain) are an appropriate measure for moderate pain. Opioids should be chosen
based on pain type; potential adverse reactions; and patient preference and comorbidities.
Opioids can be safely used for pain control in the hospice population, but risk evaluation
and mitigation strategies must be in place to minimize potential adverse reactions and
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maximize pain relief and quality of life. These medications should always be prescribed
with a bowel regimen to prevent constipation and additional pain related to the bowels.
All patients should have a moderate breakthrough opioid medication on board from time
of admission. In cases of increasing moderate pain, an adjunct therapy should be
considered. These patients should also utilize holistic measures for pain management
such as: heat or cold therapy, massage, reiki relaxation, music therapy, touch therapy,
aromatherapy, tens therapy and family presence.

Recommendation 5: Severe pain treatment by diagnosis
Patients admitted with a diagnosis which would carry a “severe” pain rating such as:
metastasized cancers, mechanical fall with broken bones, MVA with trauma, any trauma
patient, end stage vascular dementia, untreated hemorrhagic stroke, acute MI and other
similar illnesses., Use a long-acting or extended-release opioid with acetaminophen,
combined with a short-acting opioid for breakthrough pain. Provide pain medication
immediately before bedtime to reduce the likelihood that the patient will be awakened by
pain during the night. Provide pain medication around the clock during awake hours to
reduce the likelihood of severe breakthrough pain. An adjuvant medication, such as an
antiepileptic drug, antidepressant, muscle relaxant or anti-anxiety medications could also
be useful in these patients. All opioid pain regimens should be prescribed with a bowel
regimen to prevent constipation related pain issues. These patients should also utilize
holistic measures for pain management such as: heat or cold therapy, massage, reiki
relaxation, music therapy, touch therapy, aromatherapy, tens therapy and family
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presence. Multimodal treatments are the most effective to manage severe pain and should
be utilized in all cases where appropriate.

Recommendation 6: Prevention of adverse reactions
Opioid adverse events, such as severe constipation, nausea with or without vomiting, and
sentinel events such as falls with or without injury can be additional sources of pain for
our patients. Clinical staff should be proactively insuring there are protocols in place to
reduce these risks The following strategies can help manage common opioid-induced
adverse reactions:
•

Constipation- Initiate a bowel regimen immediately following a pain regimen.
This includes stool softeners, stimulants and or fiber. Increased hydration and
toileting regimen to promote defecation.

•

Nausea/Vomiting- Give pain medications with a meal or snack. Keep patients
head of bed elevated, provide plenty of fluids, avoid noxious odors and provide
antiemetics when needed.

•

Sedation/respiratory depression- Monitor 02 saturations, when possible,
encourage the use of coughing and deep breathing If the patient can comply.
Encourage repositioning and keeping the head of the bed elevated more than 40
degrees. Implement safety and fall precautions, adjust medications only if
absolutely needed. Know the difference between sedation, distress, and end-oflife processes.

